The clinical study on Gammasarcoglycanopathy sponsored by Genethon in the spotlight at the 14th Annual Meeting of the ASGCT

At its annual conference held in SEATTLE from May 18 to 21, the American Society of Gene and Cell Therapy (ASGCT) has highlighted the clinical study promoted by Genethon with Serge Herson M.D. as Principal Investigator at Hospital Pitie-Salpetriere.

This work indeed is one of four studies presented at the Presidential Symposium of the May 19 meeting.